Skip to main content
. 2020 Nov 23;10:405. doi: 10.1038/s41398-020-01089-6

Fig. 2. Malleability of gamma-evoked power after 1 h of TCT predicts overall improvement in negative symptoms.

Fig. 2

Decomposing the significant ΔγEP × treatment interaction (ΔR2 = 0.15, p = 0.01) on change in SANS symptoms revealed that the effect was largely driven by the TCT group (R2 = 0.30), but not the TAU group (R2 = 0.04).